Cargando…
APOL1 risk variants and kidney disease: what we know so far
There are striking differences in chronic kidney disease between Caucasians and African descendants. It was widely accepted that this occurred due to socioeconomic factors, but recent studies show that apolipoprotein L-1 (APOL1) gene variants are strongly associated with focal segmental glomeruloscl...
Autores principales: | Siemens, Tobias August, Riella, Miguel Carlos, de Moraes, Thyago Proença, Riella, Cristian Vidal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Nefrologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533999/ https://www.ncbi.nlm.nih.gov/pubmed/30052698 http://dx.doi.org/10.1590/2175-8239-JBN-2017-0033 |
Ejemplares similares
-
APOL1-Associated Kidney Disease in Brazil
por: Riella, Cristian, et al.
Publicado: (2019) -
What we know so far
Publicado: (2021) -
Update on omicron variant: What we know so far
por: Choudhary, Gajendra, et al.
Publicado: (2022) -
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021) -
COVID-19 and the kidney: what we think we know so far and what we don’t
por: Farouk, Samira S., et al.
Publicado: (2020)